CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ANNX

Tanruprubart

Phase 3
Annexon, Inc. (ANNX)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
ANNXPhase 3

Tanruprubart Phase 3 Est. Readout

Tanruprubart
Q2 2027~Q
CT.gov
00%
Competitive Landscape

1 competitor in Guillain-Barre Syndrome

View Full Landscape
Drug Information

Target Indication

Guillain-Barre Syndrome

Clinical Trial

NCT07020819

Last updated: 12/16/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.